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Antimicrobial resistance continues to outpace the development of new chemotherapeutics. Novel pathogens
continue to evolve and emerge. Public health innovation has the potential to open a new front in the war of “our
wits against their genes” (Joshua Lederberg). Dense sampling coupled to next generation sequencing can increase
the spatial and temporal resolution of microbial characterization while sensor technologies precisely map physical
parameters relevant to microbial survival and spread. Microbial, physical, and epidemiological big data could be
combined to improve prospective risk identification. However, applied in the wrong way, these approaches may
not realize their maximum potential benefits and could even do harm. Minimizing microbial-human interactions
would be a mistake. There is evidence that microbes previously thought of at best “benign” may actually enhance
human health. Benign and health-promoting microbiomes may, or may not, spread via mechanisms similar to
pathogens. Infectious vaccines are approaching readiness to make enhanced contributions to herd immunity. The
rigorously defined nature of infectious vaccines contrasts with indigenous “benign or health-promoting
microbiomes” but they may converge. A “microbial Neolithic revolution” is a possible future in which human
microbial-associations are understood and managed analogously to the macro-agriculture of plants and animals.
Tradeoffs need to be framed in order to understand health-promoting potentials of benign, and/or health-
promoting microbiomes and infectious vaccines while also discouraging pathogens. Super-spreaders are currently
defined as individuals who play an outsized role in the contagion of infectious disease. A key unanswered question
is whether the super-spreader concept may apply similarly to health-promoting microbes. The complex interactions
of individual rights, community health, pathogen contagion, the spread of benign, and of health-promoting
microbiomes including infectious vaccines require study. Advancing the detailed understanding of heterogeneity in
microbial spread is very likely to yield important insights relevant to public health.
Keywords: Precision medicine, Vaccines, Infectious vaccines, Public health, Precision public health, Infectious
disease, Epidemiology, Bioethics, Microbiome, Healthy buildingsBackground public health in the pre and the post
antibiotic eras
The antibiotic era began in the 1940’s. A trend toward
decreasing mortality from infectious diseases began fifty
years earlier in the late nineteenth century [1]. At least
three quarters of the decrease in mortality from infec-
tious disease from 1900 to the present day era appears
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tances to antimicrobials are increasingly common and
threaten an end of the era of reliable treatment. It is
“our wits against their genes” without a clear advantage
to the former [2]. New antimicrobials will be discovered
and developed but new resistances will arise. The con-
tinuing power of antimicrobials is at risk and alternatives
must be actively considered [3, 4]. Personalized and/or
Precision public health could fit under already-existing
rubrics of prevention via surveillance and sanitation. Al-
ternatively, these approaches may be considered radical
and different enough to suggest Personal and Precisionle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Fig. 1 Crude death rate for infectious diseases – United States, 1900–1996 (adapted by the CDC from [112]). Mortality from infectious diseases began
to decrease before the advent of antimicrobials. The slope of decrease in crude mortality does not show evidence of being affected by the
introduction of antimicrobials. The first clinical use of sulfonamids was in 1935, penicillin in 1943, with others throughout the following decades, albeit
with decreasing frequency of novel compounds. The 1918 spike in mortality was caused by the Spanish flu pandemic which is estimated to have
infected 500 million people, one third of the world’s population at that time, and killed between twenty and fifty million people
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emphases.
The meaning and scope of the terms Personalized and/
or Precision Public Health are a subject of current debate
[5–9]. There is controversy about what Precision Public
Health encompasses, how new the parts are, and what
value they may or may not have. Some differences in the
present article compared to other expositions should be
noted. Here we: 1) Emphasize monitoring physical charac-
teristics in ‘smart buildings’ 2) De-emphasize the contribu-
tion of human genomic DNA sequences. As a related
remark, susceptibility to infectious diseases is more likely
to have a meaningful and robust genetic component in
the young than in adult or aged individuals [10]. 3)
Emphasize finding the optimum granularity. By “granular-
ity” we mean the size, time, or other divisions for which
heterogeneity is most meaningful. We hypothesize the in-
dividual human being as likely to represent an especially
meaningful level of granularity with regard to the micro-
bial environment. 4) Future-oriented scenarios that antici-
pate Precision Public health promoting the spread of
health-promoting microbiomes including, but not limited
to, infectious vaccines.
Heterogeneity in biology
Technical innovations that allow higher resolution scru-
tiny have led to progress- even revolutions- in manysubfields of biology. Examples include dividing tissues
into cellular subtypes [11], single cell expression profiles
from defined anatomy, cell types, or developmental line-
ages [12–14], and cells themselves fractionated into or-
ganelles [15]. An analogous revolution in public health
might be possible through higher resolution mapping of
relevant parameters.
This commentary focuses on technologies for, and the
consequences of, increased spatial and temporal reso-
lution of microbiological, chemical, physical, spatial and
temporal measurements relevant to public health. There
is a “chicken and egg” or “Catch 22” problem in antici-
pating the benefits of higher-resolution data. This limita-
tion follows from our current ignorance of how
heterogeneous the relevant physical and microbiological
parameters are. New insights and benefits are likely
to be proportional to how much heterogeneity is
discovered as a consequence of gains in resolution.
To begin research that might crack the chicken and
egg problem, one must initially speculate on the
relevant heterogeneity. By hypothesis, a relevant
unit of heterogeneity to consider for airborne infec-
tion will be at the level of each individual human
being. The scales at which heterogeneity is hypothe-
sized to exist affect the research programs to search
for it. The results will subsequently be used to
modify the hypotheses and research program.
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sections.
The technical means and value of increasing spatial
and temporal resolution in other areas of public health,
such as ensuring healthy drinking water [16] and opti-
mal transformation of sewage [17] or compost, [18] will
not be covered here.
The human exposome is currently defined elsewhere
as the sum of an individual’s lifetime exposure to mi-
crobes and chemicals [19]. We suggest that this defin-
ition of the human exposome misses vital elements of
what matters and the definition could usefully be ex-
tended in two related ways: 1) It should explicitly in-
clude microbes and chemicals sourced directly from
other humans which probably are a major contributor in
many circumstances and 2) The exposome should be
understood as a reciprocal and interactive process to ac-
count for the fact that each individual is both a source
and a sink of microbes and chemicals. The current def-
inition of the exposome seems to consign a role to indi-
vidual humans as passive recipients or victims of their
environment. This is a valid way to model parts of the
system, including the political system, but it is biologic-
ally an incomplete description of the consequences of
our being social animals. Individual humans are major
microbiological and probably chemical contributors to
their immediate environment. Humans in proximity are
exposed to each other’s microbiomes and chemicals.
Some of this is classical epidemiology of infectious dis-
ease, such as transmission of human-specific viruses in-
cluding influenza. Some chemical influences might be
classed as behavioral, e.g. cigarette smoke and the ex-
perience of second hand smoke. However, it is also
plausible that significant chemicals that modify the
exposome of self and of others arise via the microbiome
or other metabolic sources over which an individual has,
at present, no means of knowledge or control.
Mapping what matters for human-relevant
microbes and microbiomes
Tang et al. propose more precisely mapping the global
epidemiology of non-influenza RNA respiratory viruses,
based on the whole genome sequencing of these viruses
[20]. We are supportive of this and other related
large-scale data-mining projects, i.e. with the aim that
such efforts yield copious and interpretable data. Infor-
mation currently undiscovered might also be obtained
using a different approach to sampling, particularly
air-sampling.
Current air sampling strategies concentrate microbes
from larger volumes (liters to hundreds cubic meters) of
air into smaller volumes of liquid (either directly or from
filters that are extracted) [21]. Concentration econo-
mizes the use of reagents and may (depending oninhibitors and dilution effects) minimize the frequency
of assays that yield no signal. However, vacuum sampling
alter airs flow making it a biological instantiation of the
Heisenberg uncertainty principle whereby the act of
measurement affects the object of measurement. This
sampling approach makes a trade-off between sensitivity
and localization.
How much heterogeneity is there in the spatial and
temporal distribution of microbes in the built environ-
ment? Airborne fungi in different rooms vary across sea-
sons in residences [22]. The microbial exposure where
infants crawl and young children toddle is distinct from
that at the level where adults are breathing [23, 24]. In a
case study reported in this issue, Tang et al. find that in-
dividual samplers on different individuals varied from
zero RSV RNA copies to a high of 2778/m3. It is cur-
rently unknown how much heterogeneity is inside the
cubic meter that contains thousands of genomes. At the
extremes, the entire viral load could have been confined
to one compact particle or, alternatively, it could have
been evenly dispersed through the entire volume.
Sequences or detection alone are not the only informa-
tional product. The usefulness of spatial and temporal
metadata depends on how much they reveal heterogen-
eity. PCR can now be carried out inside nanoliter or pico-
liter volumes with many millions carried out in parallel
and rare hits separated by Florescence Activated Cell Sort-
ing (FACS) from a majority of negative droplets [25]. Sin-
gle molecule sequencing is becoming routine and
molecules can uniquely labeled with barcoded primers.
What remains to be invented are ways to combine barcod-
ing with nanodrop assays and single molecule sequencing
such that each molecule’s sequence or nanoliter drop PCR
assay can be linked to its unique metadata. Small droplet
assays are likely to decrease background due to contamin-
ation of molecular reagents with bacterial DNA [26].
Rapid and focused public health actions motivated by
precision data could lead to less overall disruption and
more efficient prevention [27]. For example, if infected
animals can be reliably identified, there may be less need
to cull larger groups. Individual cattle, pigs and chicken
cages are already identified in current agricultural set-
tings to allow the tracing of Bovine Spongiform Enceph-
alopathy (BSE) [28]. Globally, approximately 20% of
livestock are lost to preventable diseases, costing around
USD $2 billion per annum in Africa alone, with much of
this loss in low- and lower-middle income settings [29].
There is substantial potential for veterinary, human pub-
lic health and economic benefit.
Toward improved microbial sampling in the built
environment
A widely cited survey estimated that most people in the
US spend 90% or more of their time either inside
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apply in buildings and more broadly for example ships,
subways, and airplanes. Most potentially consequential
microbial exposure probably occurs in these venues [31].
There are three sources of microbes in buildings [32]: a)
occupants, i.e. people and other animals if present b)
penetration from the outside environment c) growth in/
on the structure itself e.g. walls, pipes and on surfaces
that are intermittently wet [33]. Microbial growth in gar-
bage, among foodstuffs, on furnishings and cloths con-
tributes in some cases [34]. The contribution of each
source to the medically relevant microbiome is not
equally distributed. Most airborne viruses that infect
humans spread from other humans although zoonotic
transmission in farms and markets should not be
overlooked.
Heterogeneity and sampling
The optimum mode of sampling depends on the distri-
bution of targets. If the target is rare and evenly distrib-
uted, then gathering as much of the environment as
possible into each sample is best. However, if the target
is unevenly distributed, then smaller sample sizes may
be better so that rare targets are not diluted below the
detection threshold. If the environment or reagents also
contain inhibitors or decoy targets, then large scale con-
centration may decrease sensitivity. Taq polymerase and
many other reagents contain bacterial DNA that is re-
sidual from their production. Assays that use minimal
amounts of Taq decrease this background [26] and small
volumes assays should further help.
For the detection of Biowarfare agents that are nor-
mally absent and for which quick, specific, and sensitive
detection are paramount, many thousands of liters of air
rapidly collected are appropriate [35]. On the other
hand, to best understand the undisturbed environment
the sampling method should be gentle, not itself create
additional airflow, and it should be granular. Individual
vacuum samplers are an intermediate methodology.
They are worn or left near a patient and draw air onto a
filter. Depending on the airflow rate they sample a
variable-sized environment. The time resolution is typic-
ally one to several hours. As currently used the whole
filter, which is typically 25 mm in diameter is extracted
as a single sample [36, 37].
Insight into heterogeneity of the air might be gained
through a modification of the way that the sampling fil-
ter is currently processed. Instead of extracting the filter
in one piece, suppose it were cut into a number of equal
segments that are processed and assayed independently.
If most segments are negative but a few contain a strong
signal that would be clear indication of heterogeneity in
the air volume sampled. This reasoning and experimen-
tal design take their inspiration from classic studies thatdetermined the independence of bacterial mutation from
its subsequent selection [38, 39].
Individual passive sampling
If spatial and temporal variation are high, then smaller
more localized and less mixed samples become relatively
advantageous. The mouth and nose are the expected
source and the reservoir for most airborne infectious
agents. Dilution into the air volume predicts that the
concentration of an airborne agent will decrease as a
cubic function of distance from its source. Deactivation
of viruses in aerosol may lead to a more dramatic
drop-off of viable virus. Samplers should be unobtrusive
and not alter the sampled environment. The assay of
tiny volumes and the ability isolate rare positive samples
recommend a new generation of small volume and/or
passive samplers.
Clothing is a promising personal environmental sam-
pling site [40, 41] but difficult to standardize. One might
build on the clothing idea to design defined samplers
optimized for capture and preservation of the microbial
and chemical environment. Sampling material might be
housed in specially-designed holders, akin to radiation
badges. For example, in hospitals, all patients, staff and
visitors might wear standardized samplers.
The top of the shoulders appears to offer a minimally
obtrusive yet maximally sensitive sampling site.
Top-of-the-shoulder samplers would be closer to the
mouth and nose than samplers worn as chest badges but
relative sensitivity remains to be tested. Epaulettes such
as those worn as military insignia might provide design
inspiration. These approaches would potentially dovetail
with simultaneously tracking movements within the en-
vironment of interest, and thus early consideration of
the ethical issues and public or user concerns would be
critical.
Passive samplers have different characteristics that in
some scenarios may make them superior to
vacuum-enhanced air sampling: i) if the target distribu-
tion is highly heterogenous in space, then source prox-
imity may give the highest signal to noise ratio. ii) the
related ability to identify the source with less distortion
due to the sampler’s altering airflow. Each sampling
patch could contain internal standards. Research to de-
sign samplers might take inspiration from materials for
replica plating of bacteria [39, 42]. There may even be
specific overlap of optimal materials such as velveteen (a
velvet-like cloth) for capture.
Prospective identification of super-spreaders
Super-spreaders or super-shedders are individuals who
disproportionately infect others and may dominate the
epidemiology of infectious disease [43–46]. In some con-
texts super-spreaders of infectious agents might be
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by post facto epidemiology [47, 48]. Asymptomatic
super-spreaders of airborne infections might be identi-
fied as those whose samplers harbor the most signal for
the agents in question [48]. Super-spreaders or
super-shedders have been documented in people and
also among cattle and in mouse model systems [49, 50].
There are important unknowns concerning
super-spreaders. A study in cattle argues that
super-shedding may be time rather than individual
dependent, i.e. the same individuals may not be
super-spreaders a mere few hours later [51]. It is cur-
rently unclear- in fact the question appears to be un-
asked- whether super-spreaders are agent-specific or
generalized. By further hypothesis generalized
super-spreaders might excrete more of their own DNA
as well as that of infectious agents. In this case the de-
tection of spreading potential might be seen in two
ways:
i) by the presence of more self-sequences on the indi-
vidual’s samples and ii) by the presence of individual
sequence-specific DNA from the sampling of others.
The anticipation would be that those who shed either
the “wrong”, i.e. potential pathogen, or perhaps simply
too much, DNA may be considered candidates for a var-
iety of control measures, up to and including
confinement.
Rational discussions about policy and human rights
should be informed by facts [52]. Not all infections
spread between individuals are harmful or neutral.
Health-positive microbial spreading, e.g. the live attenu-
ated oral polio and rotavirus vaccines, also occurs.
Analogous to the way that some individuals are more in-
fluential than others in spreading ideas or memes [53],
some may be more influential in spreading
health-promoting microbiomes. If social and environ-
mental transmission of benign and of positively helpful
microbiomes turns out to be the case, will it follow the
same rules as the spread of detrimental infections? De-
pending on their resident microbiomes, the same indi-
viduals may turn out to be super-spreaders of benign,
health-promoting, or harmful microbes.
Toward mapping the 3D topography of relevant variables
The survival and distribution of airborne infectious
agents depends on temperature, humidity [54–60] and
airflow [61, 62]. Improved mapping of these parameters
would better inform building design, and real-time mon-
itoring of these parameters in occupied buildings might
open the way for their dynamic optimization. For ex-
ample, there is generally a temperature difference be-
tween indoor and outdoor environments, which results
in a temperature gradient across rooms whose windows
or walls form a building’s exterior. Regions of everyintermediate temperature and relative humidity will exist
when the outside is below freezing and the inside is
warm. Temperature gradients necessarily traverse the
dew point where water vapor condenses into liquid. The
stability of regions where water vapor liquifies, and the
consequences for microbes are complex and
situation-specific. Moreover, most things microbial in
the built environment also depend on the behavior of
occupants. It is therefore challenging for modelling to
predict, for example, that a specific region of hospital
room, such as the southeast corner near the ceiling, hap-
pens to be in a “sweet spot” for bacteria or virus.
An increasing number of ‘smart’ buildings, including
hospitals, are fitted with sensors [63–65] which monitor
temperature and/or humidity at a given position and are
networked in an Internet of Things (IoT) [66, 67]. These
IoT systems can provide 3D maps of the monitored pa-
rameters in real-time, and can be used e.g. to optimize
heating, ventilation, and air conditioning (HVAC) sys-
tems [68, 69] or to monitor the integrity of the building
structure [70]. Such IoT systems could be readily
adapted for applications targeting the microbiome, with
additional sensors placed in at-risk areas. Sensors can be
installed during building construction, retrofitted per-
manently, or temporarily installed. The IoT systems
could be augmented with other sensors to monitor e.g.
levels of particular gas types or volatile organic com-
pounds (VOC) relevant to microbial growth [71–73].
Environmental sensing will interface with wearable tech-
nology and individual-identified information [74].
In addition to the temperature and humidity informa-
tion provided by an IoT network of sensors, there is a
need for devices that provide portability, remote sensing,
and high spatial resolution. These could be used to rap-
idly assess large areas without having to install an IoT
system, monitor targets otherwise difficult to access, or
provide the cm- or mm-scale spatial resolution required
to localize problem sources.
High resolution, remote imaging of temperature is
routinely performed using infrared (IR) cameras for radi-
ometry, exploiting the dependence of the blackbody ra-
diation intensity at a given wavelength on temperature.
This IR thermal imaging can be used e.g. to identify
thermal leakage between indoor and outdoor environ-
ments [75]. Blackbody radiation is also emitted at micro-
wave frequencies. Although the emission intensity from
room temperature bodies is much lower at microwave
frequencies than at IR frequencies, microwaves can
penetrate through dielectric materials such as walls to
assess spaces hidden to visible or IR frequencies, and
can still provide spatial resolution on the mm- to
cm-scale. Whilst promising, microwave thermometry for
applications in the built-environment is at a much earl-
ier stage of development than IR cameras and requires
Thaler et al. BMC Infectious Diseases          (2019) 19:120 Page 6 of 10further development, with single-channel sensors of mod-
erate sensitivity and spatial resolution reported [76, 77].
Water in all its forms (humidity, moisture, condensa-
tion, etc.) and its distributions are often key variables for
the health of a building’s occupants [78–80]. Microwave
radiometers are used in the large scale environment for
remote measurement of atmospheric humidity. Water
vapor can be identified from its distinct absorption peak
at a frequency of 22.235 GHz in its microwave spectrum
[81], and multi-frequency measurements can be used to
detect liquid water (e.g. suspended microdrops). How-
ever, atmospheric measurements integrate over 100 s to
1000s of meters of air, and the research has not been
done to determine if indoor microwave radiometry, inte-
grating over much smaller volumes, would provide a
sufficient signal for practical humidity measurements.
It may be more immediately practical to look for water
in materials, such as walls with water leakage, which can
both drive local humidity and host infectious agents
themselves. Wet material can be indirectly detected with
IR imaging, through the resulting change in surface
temperature [75]. Direct remote sensing techniques for
indoor water are less advanced, and would require re-
search and development effort to become practical.
Microwave-based sensing is again promising, due to
its through-wall imaging capability and ability to provide
sufficient spatial resolution [82] (unlike radiation of lon-
ger wavelengths). Microwave sensors for water can be
based on the scattering of microwaves generated by an
external source, as discussed in this issue [83], with
holographic techniques able to provide 3D reconstruc-
tions of scattering objects [84, 85]. In the short to
medium term, single-channel point-sensors could be de-
veloped, with imaging performed by scanning the sensor.
As a long-term aspiration, one could envisage a camera
providing images of 3D moisture levels in real time,
similar to temperature imaging with IR cameras.
Schlieren and shadowgraph optics allow 3D imaging of
air movements at distance [86]. It remains to be seen if
these and/or other methods can be developed to nonin-
vasively monitor the full range of airflows relevant to
building occupants. A strength of microwaves are their
ability to penetrate many building materials even though
they are strongly absorbed by water and reflected by
metals. Infrared has the advantage of better specific
spectra for many materials of interest.
Real time carbon dioxide (CO2) imaging in the built
environment seems a reasonable approach to become
both practical and informative. The atmospheric concen-
tration of CO2 is about 400 ppm (ppm), 0.04% and in-
creasing at an annual rate of approximately 2-4 ppm per
year [87]. Directly exhaled human breath is between 4
and 5% CO2, approximately 100 fold more than the at-
mosphere. Increased ambient CO2 correlates well withsubjective reports of stuffy air [88] and local areas of in-
creased concentration correlate well with increased air-
borne concentrations of Mycobacterium tuberculosis
[89]. CO2 quantification is carried out with compact de-
vices that measure concentration via specific IR spectral
absorption. Wavelength-specific IR is used for earth [90]
and extraterrestrial [91] quantification of atmospheric
CO2. To our knowledge IR imaging of CO2 has not yet
been used in the built environment. If there is clear mo-
tivation to do it, then it can be done. Real time IR im-
aging of CO2 might, for example, be used to direct a
small fan into regions of high CO2 thereby dispelling
patches of stagnant air in an energy efficient manner.
Public health policymakers
The global health world is waking up to the challenges
posed by respiratory infectious diseases outbreaks, with
lessons being learned from high profile outbreaks cover-
ing coronaviruses such as SARS and MERS, and the
‘bird flu’ and ‘swine flu’ events from 2005 and 2009 [92].
The Ebola outbreak in west Africa across 2014 and
2015, although not primarily driven by respiratory trans-
mission, has also triggered international and national
level plans for dealing with communicable disease [93].
Powerful global health actors, that for example include
the World Health Organization [94], Wellcome Trust
[95], World Bank [96] and the Bill & Melinda Gates
Foundation [97], have now developed action plans, pro-
tocols, policy documents and research programs that ad-
dress some current needs and tentatively cover emerging
and future priorities. However, we feel there is much
they could still do in leading a conversation about the
future of public health, and how interventions and tech-
nology can drive both subtle and radical transformations
in this particular landscape.
Infections usually disproportionately affect the most
vulnerable populations, such as children with severe
malnutrition in resource-poor settings. An arguably
lower-profile aspect of the 2030 Sustainable Develop-
ment Goals, within the ‘no one left behind’ mantra, is
the concept of healthy ageing [98]. With an increasingly
ageing global population, we hypothesize that managing
newly-geriatric populations in low- and middle-income
settings will result in requirements for entire new med-
ical and public health specialties in countries where cur-
rently few people live in to their 70s or older. An
increasing number of older people, presenting with nu-
merous morbidities (such as cardiovascular, musculo-
skeletal complications, and dementia), will therefore not
be able to be cared for in a family home, and local equiv-
alents of care homes will be set up. The elderly institu-
tionalized remain vulnerable to infection. This will result
in development of clinical practice, and ethical and legal,
frameworks for patient management and research in
Table 1 Typhoid Mary and Minority Report
The premise of “Minority Report” (a dystopian science fiction story by
Phillip K. Dick (1956), made into a film (2002) and a television series
(2015)) is “predictive policing” that allows authorities to forecast who
will commit a crime. The “pre-offender” is preventatively detained or
killed before any crime has actually taken place. Mary Mallon, better
known as “Typhoid Mary” was an asymptomatic carrier of the typhoid
fever bacillus whose unfortunate choice of occupation was to be a
cook. Epidemiologists tracked her down, but she escaped surveillance,
changed her name and again took up the only trade she knew.
Repeatedly located by investigators who tracked down the shared
source of multiple infections, she was eventually confined against her
will with no prospect of release [113]. Finding and acting to prevent
contagion from Typhoid Mary saved lives and reduced a significant local
burden of enteric disease, even though it compromised her civil rights.
The molecular version of “Minority Report” would be to prospectively
identify Typhoid Mary rather than relying on reactive surveillance to
follow the trail of disease backwards to find its source.
Typhoid Mary is a singular and extreme case. It is also a century old. The
moral calculus has not changed with more recent cases although the
information-dissemination and decision-making machinery has, and not
always for the better [114, 115]. By considering the role that information
plays in more recent cases we try to consider how better and different
information may inform future public health policies. Anticipated tech-
nical advances to prospectively screen carriers of transmissible disease
universalize this possibility which is both an opportunity or a threat. This
commentary article discusses enabling technologies and also considers
implications for both public health and private rights.
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existing frameworks (such as the Mental Capacity Act in
the UK), and adapted to suit local needs and cultures
[99, 100].
Future public health preventive measures include
more efficiently- targeted approaches to vaccination.
The concept of transmissible vaccines is being widely
considered, and initial theoretical research has suggested
that even weakly transmissible vaccines could provide
significant benefit in reductions of disease burden [101,
102]. The additional benefit of improved vaccination
programs would be to slow the development of anti-
microbial resistance [103, 104]. However, the potential
negative consequences on vulnerable immunocomprom-
ised individuals, must be clearly considered. Public dis-
cussion concerning new vaccine programs has
sometimes been politically charged [105].
Conclusions
A data-driven dilemma in the future of public health
ethics
Public health, with reference to microbiology, utilizes
several streams of data all of which are subject to im-
provements whose combined information have the po-
tential to be synergistic: 1) identification and
quantification of microbes, their locals of growth, metab-
olism, evolution, carriers, and 2) mapping the physical
parameters that contribute to microbial survival and dis-
semination. 3) Patient and epidemiological reporting 4)
Correlation indicators such as Google searches. New
technologies will increase the temporal and spatial reso-
lution of data collection and move closer to real time ap-
prehension of the microbial environment. Higher
resolution information will inspire architectural and so-
cial designs that aim to diminish detrimental
human-pathogen encounters while enhancing those that
may be beneficial. Personal and Precision Public Health
have the potential to greatly reduce the spread of infec-
tions and the burden of antibiotic resistance both dir-
ectly by spotting antibiotic resistance genes earlier and
indirectly by decreasing the overall rate of primary infec-
tion. The displacement of antibiotic tolerant C. difficile
with microbiomes introduced via fecal transplants are
already a clinical application of introducing health-
promoting microbiomes [106]. It remains to be seen if
this is an isolated and specialized application or, more
hopefully, a harbinger of a broader future.
The realization of Precision Public Health will require
new interdisciplinary collaborations inclusive of sensor
engineers, microbiologists (both medical and environ-
mental), building engineers, architects and bioethicists.
Focused multi-disciplinary training programs in high-
income settings can lead the way for significant know-
ledge and skill transfer into low- and middle-incomesettings. Fine grained spatial and temporal mapping of
physical and biological parameters along with reduced
lag between data gathering and interpretation will pro-
gress toward real time analysis. Transformative benefits
in personal care via personal and precision medicine are
widely touted [107] but we assert that personal and Pre-
cision Public Health offer opportunities for impact at
greater scale.
Ethical issues that encompass work, civil, and human
rights need to be considered right from the very start of
planning around Precision Public Health. The public
must have a say in these future public health initiatives.
Retrospective public and community engagement can
lead significant and harmful loss of trust in public
health, as demonstrated in the UK with the failed imple-
mentation of the care.data digital health program [108],
and in Denmark where unwarranted anti-vaccine mes-
sages about the HPV vaccine overwhelmed a limited
health promotion campaign [109].
In the event of infection with highly-infectious or ser-
ious pathogens, people- no one can say yet how many-
may be excluded from their chosen work, travel, or even
confined against their will based only on their predicted
and unintended likelihood of spreading disease. It would
be a new kind of sequence-based discrimination and the
incriminating sequences would not even be their own.
On the other hand, with appropriate intervention that
may include confinement, the spread of contagion might
be greatly diminished in many circumstances, with work
and health of the entire group- especially the most im-
munologically vulnerable- greatly enhanced. Who could
Thaler et al. BMC Infectious Diseases          (2019) 19:120 Page 8 of 10argue against increasing the safety of hospital workers
and patients? Who could argue against greater microbio-
logical safety and health for the crew of long term space
flights who live at close quarters for months at a time
[110]? If there were clear evidence for wider public
health benefit, how could we not do this? Even in Ty-
phoid Mary’s day (early 1900’s, See Table 1) asymptom-
atic carriers of the typhoid bacillus could be identified
through individual stool samples. Present and foresee-
able technologies make us all candidates for routine high
resolution screening. Future approaches to sampling in
Precision Public Health will ideally be unobtrusive but
consequences, i.e. how the information is used, are part
and parcel of generalized changes to the practical as well
as philosophical aspects of privacy, individual rights, and
free will [111] that merit as much forethought with all
the relevant stakeholders as the technology.
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